Haldol Drops Dosage/Direction for Use

The dosages as suggested as follows are only averages; one should always try to tailor the dose to the patient's response. This often implies an upward titration in the acute phase, and a gradual reduction in the maintenance phase, in order to determine the minimal effective dose. Higher doses should only be given to patients responding poorly to lower dosages.
Adults: As a neuroleptic agent: Acute phase: acute episodes of schizophrenia, delirium tremens, paranoia, acute confusion, Korsakoff's syndrome, acute paranoia.
5-10 mg IM, to be repeated hourly until sufficient symptom control is achieved or up to a maximum of 60 mg/day. When given orally, nearly double the previously mentioned dose may be needed.
Chronic phase: chronic schizophrenia, chronic alcoholism, chronic personality disorders.
1-3 mg orally TID, may be increased to 10-20 mg TID, depending on the response.
As a psychomotor anti-agitation agent: Acute phase: mania, dementia, alcoholism, personality disorders, behaviour and character disorders, singultus, choreatic movements, tics, stuttering.
5-10 mg IM.
Chronic phase: 0.5-1 mg TID orally, may be increased to 2-3 mg TID, if required, to obtain a response.
As an adjuvant in chronic pain therapy: 0.5-1 mg TID orally, may be adjusted if needed.
As an anti-emetic: Centrally induced vomiting: 5 mg IM.
Prophylaxis of postoperative vomiting: 2.5-5 mg IM at the end of surgery.
In elderly patients: Treatment should start with half the dosage stated for adults and adjusted according to the results if necessary.
In children: 0.1 mg/3 kg body weight TID orally; may be adjusted if needed.